NeoStem obtains exclusive license to innovative stem cell procedure treating musculoskeletal diseases
NeoStem Inc, which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, has signed an exclusive royalty-bearing license agreement for the Asia territory to use an innovative process that rapidly grows a patient’s own adult stem cells to treat a variety of musculoskeletal diseases.
[Read the full article here]Related News:
NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell … – MSN MoneyCentral
NeoStem gets worldwide licence to stem cell tech for skin therapies (PharmaBiz)